ORIGINAL ARTICLE

Cell Research (2008): 1105-1113
© 2008 IBCB, SIBS, CAS All rights reserved 1001-0602/06 $ 30.00
www.nature.com/cr

PLP2, a potent deubiquitinase from murine hepatitis virus, strongly inhibits cellular type I interferon production

Dahai Zheng¹, Gang Chen^1,3, Beichu Guo², Genhong Cheng^1,2 and Hong Tang¹

Correspondence: Hong Tang, Tel: +86-10-64888438; Fax: +86-10-64848357 E-mail: tanghong@moon.ibp.ac.cn; Genhong Cheng, Tel: +1-310-825-8896; Fax: +1-310-206-5553 E-mail: gcheng@mednet.ucla.edu

Download as printable (PDF) file Full Text (html)file Search Medline for articles by: Dahai Zheng

Infections by coronaviruses such as severe acute respiratory syndrome (SARS) coronavirus (SCoV) and mouse hepatitis virus A59 (MHV-A59) result in very little type I interferon (IFN) production by host cells, which is potentially responsible for the rapid viral growth and severe immunopathology associated with SARS. However, the molecular mechanisms for the low IFN production in cells infected with coronaviruses remain unclear. Here, we provide evidence that Papain-like protease domain 2 (PLP2), a catalytic domain of the nonstructural protein 3 (nsp3) of MHV-A59, can bind to IRF3, cause its deubiquitination and prevent its nuclear translocation. As a consequence, co-expression of PLP2 strongly inhibits CARDIF-, TBK1- and IRF3-mediated IFN reporter activities. In addition, we show that wild-type PLP2 but not the mutant PLP2 lacking the deubiquitinase (DUB) activity can reduce IFN induction and promote viral growth in cells infected with VSV. Thus, our study uncovered a viral DUB which coronaviruses may use to escape from the host innate antiviral responses.

Cell Research (2008) 18:1105–1113. doi: 10.1038/cr.2008.294; published online 28 October 2008

Keywords: MHV-A59, PLP2, deubiquitination, IRF3, type I interferons